menu
    • menu

    Company profile for Pheon Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pheon Therapeutics is a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers.Pheon is utilizing its expertise, know-how and access to wholly owned, proprietary antibodies and payloads to develop a pipeline of solid tumor-targeting ADCs with the aim of treating cancers with significant unmet need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pheon Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Lawes Open Innovation Hub, Rothamsted Research West Common, Harpenden, Hertfor...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pheontx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pheon-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/pheontx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pheon Therapeutics Adds Oncology R&D Expert Dr. Blackman to Board
    Pheon Therapeutics Adds Oncology R&D Expert Dr. Blackman to Board

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pheon-therapeutics-bolsters-board-of-directors-with-oncology-rd-expert-dr-samuel-blackman-302549625.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    Pheon Therapeutics Expands Board with Appointment of Dr. Enoch Kariuki
    Pheon Therapeutics Expands Board with Appointment of Dr. Enoch Kariuki

    09 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pheon-therapeutics-expands-board-with-appointment-of-dr-enoch-kariuki-302242051.html

    PR NEWSWIRE
    09 Sep 2024
    Share Share
    Pheon Announces $120M Series B For Differentiated ADC Pipeline
    Pheon Announces $120M Series B For Differentiated ADC Pipeline

    21 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pheon-therapeutics-announces-120m-series-b-financing-to-fund-development-of-its-differentiated-adc-pipeline-302150534.html

    PR NEWSWIRE
    21 May 2024
    Share Share
    Pheon rides wave of ADC interest with $120M financing
    Pheon rides wave of ADC interest with $120M financing

    20 May 2024

    // Gwendolyn Wu BIOPHARMADIVE

    https://www.biopharmadive.com/news/pheon-therapeutics-adc-antibody-drug-series-b/716502/

    Gwendolyn Wu BIOPHARMADIVE
    20 May 2024
    Share Share
    Pheon Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer
    Pheon Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer

    25 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pheon-therapeutics-appoints-industry-veteran-cyrus-mozayeni-md-as-chief-executive-officer-301884123.html

    PR NEWSWIRE
    25 Jul 2023
    Share Share
    Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
    Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals

    05 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pheon-therapeutics-enters-into-license-agreement-with-biocytogen-pharmaceuticals-301870046.html

    PR NEWSWIRE
    05 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search